Frontline Brentuximab Vedotin As Monotherapy or in Combination for Older Hodgkin Lymphoma Patients

Christopher A. Yasenchak; Rodolfo Bordoni; Dipti Patel-Donnelly; Timothy Larson; Jerome Goldschmidt; Ralph V. Boccia; Vivian J.M. Cline; Mariana Sacchi; Andres Forero-Torres; Robert B. Sims; Jingmin Liu; Jonathan W. Friedberg

doi:10.1182/BLOOD-2020-136583

Frontline Brentuximab Vedotin As Monotherapy or in Combination for Older Hodgkin Lymphoma Patients

Christopher A. Yasenchak
, Rodolfo Bordoni
, Dipti Patel-Donnelly
, Timothy Larson
, Jerome Goldschmidt
, Ralph V. Boccia
, Vivian J.M. Cline
, Mariana Sacchi
, Andres Forero-Torres
, Robert B. Sims
, Jingmin Liu
, Jonathan W. Friedberg

Willamette University
Georgia Cancer Specialists, Marietta, GA
Virginia Cancer Specialists, Fairfax, VA
Minnesota Oncology P.A., Minneapolis, MN
Oncology and Hematology Associates of SW Virginia, Blackburgs, VA
Center for Cancer and Blood Disorders, Bethesda, MD
U.S. Oncology Associates, Austin, TX
Bristol-Myers Squibb
Seattle Genetics
University of Rochester Medical Center

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Blood
Volume	136
DOIs	https://doi.org/10.1182/BLOOD-2020-136583
State	Published - Nov 5 2020
Externally published	Yes

Disciplines

Medicine and Health Sciences
Oncology
Internal Medicine

Access to Document

10.1182/BLOOD-2020-136583License: Unspecified

Cite this

@article{c718a74081c84694a3665e93ebcb49ff,

title = "Frontline Brentuximab Vedotin As Monotherapy or in Combination for Older Hodgkin Lymphoma Patients",

author = "Yasenchak, \{Christopher A.\} and Rodolfo Bordoni and Dipti Patel-Donnelly and Timothy Larson and Jerome Goldschmidt and Boccia, \{Ralph V.\} and Cline, \{Vivian J.M.\} and Mariana Sacchi and Andres Forero-Torres and Sims, \{Robert B.\} and Jingmin Liu and Friedberg, \{Jonathan W.\}",

note = "Oral and Poster Abstracts Oral 624. Hodgkin Lymphoma and T/NK Cell Lymphoma-Clinical Studies: Clinical Studies in Hodgkin Lymphoma Biological, antibodies, Diseases, Hodgkin Lymphoma, Therapies, T-Cell Lymphoma, Lymphoid Malignancies Christopher A. Yasenchak, MD 1, Rodolfo Bordoni, MD 2 *, Dipti Patel-Donnelly, MD 3, Timothy Larson, MD 4 *, Jerome Goldschmidt, MD 5 *, Ralph V.",

year = "2020",

month = nov,

day = "5",

doi = "10.1182/BLOOD-2020-136583",

language = "American English",

volume = "136",

journal = "Blood",

publisher = "American Society of Hematology",

}

TY - JOUR

T1 - Frontline Brentuximab Vedotin As Monotherapy or in Combination for Older Hodgkin Lymphoma Patients

AU - Yasenchak, Christopher A.

AU - Bordoni, Rodolfo

AU - Patel-Donnelly, Dipti

AU - Larson, Timothy

AU - Goldschmidt, Jerome

AU - Boccia, Ralph V.

AU - Cline, Vivian J.M.

AU - Sacchi, Mariana

AU - Forero-Torres, Andres

AU - Sims, Robert B.

AU - Liu, Jingmin

AU - Friedberg, Jonathan W.

N1 - Oral and Poster Abstracts Oral 624. Hodgkin Lymphoma and T/NK Cell Lymphoma-Clinical Studies: Clinical Studies in Hodgkin Lymphoma Biological, antibodies, Diseases, Hodgkin Lymphoma, Therapies, T-Cell Lymphoma, Lymphoid Malignancies Christopher A. Yasenchak, MD 1, Rodolfo Bordoni, MD 2 *, Dipti Patel-Donnelly, MD 3, Timothy Larson, MD 4 *, Jerome Goldschmidt, MD 5 *, Ralph V.

PY - 2020/11/5

Y1 - 2020/11/5

UR - https://ash.confex.com/ash/2020/webprogram/Paper136583.html

U2 - 10.1182/BLOOD-2020-136583

DO - 10.1182/BLOOD-2020-136583

M3 - Article

VL - 136

JO - Blood

JF - Blood

ER -

Frontline Brentuximab Vedotin As Monotherapy or in Combination for Older Hodgkin Lymphoma Patients

Disciplines

Access to Document

Other files and links

Cite this